AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Deferred Taxes (2021)

Updated

AbCellera Biologics' Deferred Taxes was $1.96 million in FY2023, compared with -$2.11 million in FY2022.

Analysis

AbCellera Biologics (ABCL) Deferred Taxes (2021) Analysis & Trends

From FY2020 onward, AbCellera Biologics has reported Deferred Taxes for 4 years.

  • Deferred Taxes shows a three-year compound annual growth rate of -2.2% (FY2020 to FY2023).
  • The FY2023 figure marks the highest annual Deferred Taxes since FY2020.
  • Per Business Quant data, Deferred Taxes in earlier years was -$2.11 million in FY2022, -$2.02 million in FY2021 and $2.1 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -479.00 Mn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -195.00 Mn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 AbCellera Biologics 3.89 Bn 3.89 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 1.25 Mn
Sep 30, 2021 -4.02 Mn
Jun 30, 2021 133,000.00
Mar 31, 2021 623,000.00
API Access

AbCellera Biologics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=ABCL&period=max&api_key=YOUR_API_KEY